Innoviva, Inc., 10% Owner at Entasis Therapeutics Holdings Inc. (ETTX), bought 12,677,490 shares at $2.50 ($31.7M) on 2020-06-11, disclosed to the SEC on 2020-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ARMP | BUY | 2021-03-17 | $27.9M | — | Filing → |
| ETTX | BUY | 2020-09-01 | $25.0M | — | Filing → |
| ARMP | BUY | 2020-03-31 | $44.3M | — | Filing → |